 ATLANTA, Nov. 19, 2020 PRNewswire -- CryoLife, Inc. NYSE: CRY, a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investors and analysts to discuss progress with the Companys ongoing PROACT Xa trial on December 7,... 